News

Allergan will receive a CA$500,000 upfront payment from BLS which will be followed by subsequent additional payments based on net sales. Valeant Pharmaceuticals is a specialty pharmaceutical company

The research, conducted using Thermo Scientific mass spectrometers, provides insight into key areas of stroke evaluation and treatment. The collaboration between the BRIMS Center and Harvard University has

The overall program from initiation to delivery of optimized liposome formulations of GAP-107B8 to PharmaGap suitable for in-vivo studies is expected to take approximately 4 months. Initial analysis

The patent includes claims to methods of preparing glatiramer acetate drug product, marketed as Copaxone. Momenta, a biotechnology company specializing in the characterization and engineering of complex drugs,

Servier and Galapagos entered into the alliance in July 2010 to build on novel OA drug targets discovered by Galapagos through its proprietary platform. Galapagos is responsible for

DSM Biologics provides and develops technologies relevant for optimized mammalian cell culture processes. The contract covers the process development and cGMP manufacturing by DSM of their lead product

Daniel had blamed the company for getting breast cancer after taking its Prempro menopause drug, bloomberg.com reported. A Pennsylvania appeals court overturned a ruling that Pfizer’s Wyeth unit

SironRX is a spinoff of the privately-held biotechnology company Juventas Therapeutics which licensed the drug’s intellectual property from Cleveland Clinic in 2007. SironRX’s lead drug JVS-100 contains an

The BLISS-52 study, one of two pivotal Phase 3 trials, was designed to evaluate the efficacy and safety of belimumab plus standard of care, versus placebo plus standard